$MSLP..nice piece.. If you are a micro cap investor

New Post Public Reply Private Reply Replies (0) Message Board
junewong

$MSLP..nice piece..

Is MusclePharm (MSLP) For Real, or is it SpongeTech Part Deux?

If you are a micro cap investor like me, you always enjoy a good story.  Most micro cap or penny stock traders/investors remember the whole SpongeTech (now defunct) debacle of 2010.  The story was pretty simple.  SpongeTech was a company with 2 billion+ shares outstanding selling a product all over TV and advertising the product at every major sporting event on planet earth. This equation led to SpongeTech’s stock rising from sub penny to over 20c per share ($400m market cap at its height).  The SEC charged the company in 2010 with running a Pump & Dump scheme, and the stock fell to zero along with the company. 

MusclePharm (MSLP) first got introduced to me a couple weeks ago (I do not own shares) by some legit investors I know as a turnaround story with the hopes that the company will look more like a “big boy-girl” company over the next couple months.  The company currently has 1.6 billion shares out if you include all the convertible securities, and I would expect the company to do a large reverse split at some point.

So with that as a backdrop, what does MusclePharm do?

MusclePharm is a healthy life-style company that develops and manufactures a full line of NSF International and Informed Choice approved nutritional supplements that are free of banned substances. Based on years of research at the MusclePharm Sports Science Center, the products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than one hundred elite professional athletes from various professional sports leagues including the National Football League, Mixed Martial Arts and Major League Baseball. The Company’s products address all categories of an active lifestyle, including muscle building, weight loss and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in more than 120 countries and available in over 10,000 U.S. retail outlets, including Dick’s Sporting Goods, GNC, Vitamin Shoppe, Vitamin World and Walmart. MusclePharm products also are sold through more than 100 online stores, including bodybuilding.com, Amazon.com and Vitacost.com. For more information, please visit www.musclepharm.com .

The company has pro athlete endorsements from several well known NFL players including Michael Vick, Chad Ochocinco, Patrick Willis, Joey Porter and most of the top ranked UFC (MMA) fighters: Anderson Silva, Dominick Cruz, Jose Aldo, Rampage Jackson, Rashad Evans, Clay Guida, and others.

The numbers are impressive…

The company has grown from $20m in revenues for FY 2011, and expects FY 2012 revenues of $75m .   In fact MSLP expects to do $19m in revenues in Q1 2012, almost what the company did for the full year in 2011.  With this growth rate and highly visible brand I expect this company to attract quite a lot of attention over the near term.  With the stock currently at 0.02 (ish), it is trading at a $30-35m market cap.  I do not have an opinion on the company or stock, but I think this is a story that will be fun to watch.

The MicroCapClub (mc2)  is an exclusive micro cap forum focused on micro cap companies (sub $500m market cap). The MicroCapClub was created and founded by Ian Cassel as a way to share ideas and to learn from other seasoned like-minded micro cap investors. Our goal at  MicroCapClub.com  is quality membership and quality stock ideas.  If you are an experienced micro cap investor, feel free to  Apply today .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Concerns Rise Over Trump's Cryptocurrency Reserve Strategy

Updated Category News Views 192

Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...

Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments

Updated Category News Views 145

BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...

Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds

Updated Category News Views 114

Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...

Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics

Updated Category News Views 208

Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...

Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study

Updated Category News Views 34

Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...

Continue Reading